Ahead of a CMD later this afternoon, Zotefoams has set out a refreshed growth strategy and ambitious mid-term targets. It does so from a position of strength with today’s FY24 results showing record sales and profits (FY24 sales +16% at CER to £148m and adj. EBIT +20% to £18.1m), rising ROCE (to 11.7%) and a strong balance sheet (ND/EBITDA down to 0.9x). By 2029, the company is targeting sales >£200m, operating margin >18%, cash conversion >95% and ROCE >20%. M&A also features in the plans; this ....
